It is a chemicals private limited company based in Kodungallur, Kerala, India, established in 2020.
2020 | Kodungallur, Kerala, India | ActiveTriple Twelve Pharmaceuticals Private Limited, a active private limited company, was established on 05 August 2020 in Kodungallur, Kerala, India. Engaging in manufacturing within the chemicals sector, it holds CIN: U24230KL2020PTC063441. Registered under ROC Roc Ernakulam. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
Its leadership includes Sithara Sreekumar (Director), Sidharth Sreekumar (Director), Padinjarekunnath Sreekumar (Managing Director). Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at Door No.35/473,A3 Cheraman Plaza, Pallinada, Kodungallur, Kerala, 680664.
U24230KL2020PTC063441
063441
05 August 2020
₹1.00 M
₹1.00 M
Roc Ernakulam
Unlisted
Active
Explore comprehensive insights into Triple Twelve Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sithara Sreekumar | Director | 05 Aug 2020 | Current |
| Sidharth Sreekumar | Director | 05 Aug 2020 | Current |
| Padinjarekunnath Sreekumar | Managing Director | 05 Aug 2020 | Current |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Triple Twelve Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 346.64% increase. The company also saw a substantial improvement in profitability, with a 274.78% increase in profit. The company's net worth moved up by a moderate rise of 8.44%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Triple Twelve Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Triple Twelve Pharmaceuticals has a workforce of 0 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Triple Twelve Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Triple Twelve Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Triple Twelve Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was recorded as a recent event.
Triple Twelve Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ernakulam. was recorded as a recent event.
The activity Sithara Sreekumar was appointed as a Director was appointed as a Director on 05 Aug 2020 & has been associated with this company since 5 years 4 months . was completed.
The activity Sidharth Sreekumar was appointed as a Director was appointed as a Director on 05 Aug 2020 & has been associated with this company since 5 years 4 months . was completed.
Progress on Padinjarekunnath Sreekumar was appointed as a Managing Director was appointed as a Managing Director on 05 Aug 2020 & has been associated with this company since 5 years 4 months . was documented.
The activity Triple Twelve Pharmaceuticals Private Limited was registered on 05 Aug 2020 with Roc Ernakulam & aged 5 years 4 months as per MCA records. was completed.
The CIN of Triple Twelve Pharmaceuticals Private Limited is U24230KL2020PTC063441.
Triple Twelve Pharmaceuticals Private Limited is headquartered at Door No.35/473,A3 Cheraman Plaza, Pallinada, Kodungallur, Kerala, 680664.
Triple Twelve Pharmaceuticals Private Limited was incorporated on 05 August 2020.
The current directors of Triple Twelve Pharmaceuticals Private Limited are
The primary industry of Triple Twelve Pharmaceuticals Private Limited is Chemicals.
Triple Twelve Pharmaceuticals Private Limited is unlisted.
The authorized capital of Triple Twelve Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX